SATURDAY, 23.12.

2016

CARDIAC/VASCULAR/CARDIOLOGY
Hall: Pacific
08.00 -11.00 - Seminar in Thrombosis and Antithrombotic Therapy
M. Matsagkas (Greece)
Course director: M. Matsagkas (Greece)
Moderators: M. Matsagkas (Greece), I. Banzic (Serbia)
Part A - Arterial disease
08.00 08.15 Antithrombotic treatment in peripheral arterial interventions
G. Kouvelos (Greece)
08.16 08.30Antithrombotic treatment in carotid interventions
I. Banzic (Serbia)
08.31 08.45Optimal antithrombotic treatment during cardiac surgery
S. Putnik (Serbia)
08.46 09.00Antithrombotic treatment during combined cardiac surgery and carotid
intervention
M. Matsagkas (Greece)
09.01 09.10Discussion
Part B - Venous Thromboembolism

09.11 09.20Pathophysiology of heamostasis and thrombosis

N.Roussas (Greece)
09.21 - 09.35The recently published ESC guidelines for pulmonary embolism - New
treatment strategies
V. Chervenkof (Bulgaria)
09.36 - 09.50NOACs in the treatment of VTE.Clinical implications
M.Matsagkas (Greece)
09.51 10.00Discussion
Part C - Peri-operative antithrombotic management
10.01 10.40Managing patients under anti-thombotic therapy to undergo non-cardiac
surgery
E.Arnaoutoglou (Greece)
10.41 10.50Discussion
Satellite presentation
10.51 - 11.00 HEMOFARM Topic and speaker to be defined
Hall: Pacific
13.00-14.00 Articure Lunch symposium Current status and latest developments on
Sole/Hybrid AF Ablation
Moderator: Timo Weimar, MD (Germany)
13.05-13.30
Surgical Options in Sole and Hybrid Therapy Ablation Approaches
T. Weimar (Germany)

13.30-13.55
Single Stage Hybrid AF Ablation Using the Converge Approach
Mi. Zembala (Poland)
Hall: Baltic + Aegean
14. 00 -16. 00 -JOINT SESSION WITH SERBIAN SOCIETY FOR HEART FAILURE: Diabetes and
heartfailure: pathophysiology, clinical presentation and treatment
Moderators: S. Dodic (Serbia), S. Pavlovic (Serbia)
(15+5 minuta)
14.00-14.20
1. Diabetes, heart failure and advanced glycation end products: Clinicaly relevant
hidden links?
M. Mamas, (UK)
14.20-14.40
2. Dysglicaemia and heart failure phenotypes: clinical presentation and therapeutic
implications
P. Seferovic (Serbia)
14.40-15.00
3. Acute coronary syndrome in type 2 diabetes: Optimal clinical and treatment
strategies
A.Oto (Turkey)
15.00-15.20
4. Acute heart failure and diabetes: prognostic and therapeutic aspects
A.Ristic (Serbia)
15.20-15.40
5. Antiglycemic drugs in heart failure: friends or foe?
Michael Theodorakis, (UK)